Blood cancers, Myeloma
Results
Phase 2
This trial looked at a combination of KW-2478 and bortezomib for myeloma that has come back or got worse despite having other treatment.
Recruitment start: 26 May 2010
Recruitment end: 30 November 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jamie Cavenagh
Kyowa Hakko Kirin Pharma, Inc, USA
NIHR Clinical Research Network: Cancer
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 15 May 2018
CRUK internal database number: 6651
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
